#Coagulation monitoring kits Market Value | Explore Tumblr posts and blogs

rupalic · 2 months ago

Text

Driving Efficiency with Specialty Enzymes: A Look at Technological Advancements

Specialty enzymes are specific proteins designed to catalyse biochemical reactions for specialized applications in various industries. These enzymes are tailored to meet the unique requirements of different industrial processes, enhancing efficiency, specificity, and performance. The global specialty enzymes market size is estimated to be valued at USD 6.1 billion in 2024 and is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5%.

Key Applications of Specialty Enzymes:

Food and Beverage Industry:

Baking: Enzymes like amylases and proteases improve dough handling and bread quality.

Dairy: Lactases break down lactose, aiding in the production of lactose-free products.

Brewing: Proteases and beta-glucanases improve filtration and clarity in beer production.

Pharmaceuticals:

Therapeutic Enzymes: Used to treat diseases such as enzyme replacement therapies for lysosomal storage disorders.

Diagnostic Enzymes: Enzymes like glucose oxidase are used in biosensors for blood glucose monitoring.

Biofuels:

Cellulases and Hemicellulases: Break down plant biomass into fermentable sugars for ethanol production.

Lipases: Enhance biodiesel production by breaking down fats and oils.

Textile Industry:

Amylases: Remove starch-based sizing agents from fabrics.

Cellulases: Provide a soft finish to fabrics and improve color brightness.

Agriculture:

Phytases: Improve the bioavailability of phosphorus in animal feed, enhancing nutrition.

Proteases: Enhance the digestibility of feed proteins for better animal growth.

Enzymes sourced from animals hold a significant specialty enzymes market share

Animal-derived enzymes are often preferred for their high specificity and efficiency in catalyzing biochemical reactions, which is essential in various specialized processes. Pancreatic enzymes, such as trypsin and chymotrypsin, are extensively used in drug formulation and the production of biologics. These enzymes facilitate the precise cleavage of peptide bonds, crucial for developing and manufacturing therapeutic proteins and peptides. Their specificity and activity levels make them indispensable in pharmaceutical applications, significantly contributing to their market share.

Moreover, animal-derived enzymes are essential in clinical diagnostics. For example, rennet, obtained from the stomachs of calves, is used in the coagulation process for cheese production, highlighting their importance in the food industry. In clinical settings, enzymes like lactase, derived from animal sources, are used in diagnostic kits to test for lactose intolerance, demonstrating their versatility and utility in both food processing and medical diagnostics.

A notable example of the significance of animal-sourced enzymes is the use of thrombin, derived from bovine sources, in surgical procedures. Thrombin is crucial for promoting blood clotting and is used in topical hemostatic agents to control bleeding during surgeries. The high efficacy and reliability of thrombin in medical applications underscore the importance of animal-derived enzymes in the specialty enzymes market.

Factors Driving the Specialty Enzymes Market Growth

Public funding and incentives for biotechnological research are critical drivers of growth and innovation in the specialty enzymes market. The EU’s Horizon Europe program, with a budget of USD 103.6 billion for 2021-2027, is focused on research and innovation, including biotechnology. This program supports projects aimed at developing advanced biotechnological processes and products. In the United States, the National Institutes of Health (NIH) allocated over USD 42.0 billion for biomedical research in 2022, with part of this funding directed towards biotechnology research, including the development of novel enzymes for medical and industrial applications.

In India, the Biotechnology Industry Research Assistance Council (BIRAC) plays a significant role in fostering innovation and growth within the specialty enzymes market. Established by the Department of Biotechnology (DBT), Government of India, BIRAC actively supports biotech startups and research institutions through various funding schemes. One of the key initiatives is the Biotechnology Ignition Grant (BIG) scheme, which provides early-stage funding to startups and entrepreneurs with innovative ideas in biotechnology. In July 2020, BIRAC allocated Rs. 50 crores (approximately USD 6.7 million) under the BIG scheme to support around 100 startups and entrepreneurs in the biotechnology sector. This funding aims to catalyze innovation, encourage entrepreneurship, and accelerate the development of novel enzyme-based solutions for various applications in biotechnology and pharmaceuticals. By providing financial support and fostering a conducive ecosystem for research and development, initiatives like BIRAC’s BIG scheme contribute significantly to the growth and competitiveness of the enzyme market in India.

Top Specialty Enzymes Companies

BRAIN Biotech AG (Germany)

Novozymes A/S (Denmark)

Codexis, Inc. (US)

Sanofi (France)

Merck KGaA (Germany)

Dyadic International Inc (US)

Advanced Enzyme Technologies (India)

Amano Enzyme Inc (Japan)

F. Hoffmann-La Roche Ltd (Switzerland)

New England Biolabs (US)

BBI Solutions (UK)

North America region to dominate the specialty enzymes industry during the forecast period.

North America holds the highest market share in the specialty enzymes market due to several key factors. The region is home to a robust pharmaceutical and biotechnology industry, characterized by significant investments in research and development. This investment landscape fosters innovation, leading to the development of advanced enzyme-based solutions. For instance, companies like Codexis, Inc. (US), are at the forefront of enzyme engineering, continuously developing new enzymes for pharmaceutical and industrial applications.

Moreover, the presence of well-established healthcare infrastructure and a high demand for diagnostic tools contribute to the market’s growth. Specialty enzymes are crucial in various diagnostic applications, including ELISA (Enzyme-Linked Immunosorbent Assay) tests, which are widely used in medical diagnostics. The increasing prevalence of chronic diseases such as cancer and diabetes in North America drives the demand for these advanced diagnostic tools, further propelling the specialty enzymes industry.

0 notes

healthcaremarketresearchsblog · 5 months ago

Text

In-Vitro Diagnostics Market Future Prediction Report By 2030

The Insight Partners recently announced the release of the market research titled In-Vitro Diagnostic Market Outlook to 2030 | Share, Size, and Growth. The report is a stop solution for companies operating in the In-Vitro Diagnostic market. The report involves details on key segments, market players, precise market revenue statistics, and a roadmap that assists companies in advancing their offerings and preparing for the upcoming decade. Listing out the opportunities in the market, this report intends to prepare businesses for the market dynamics in an estimated period.

Is Investing in the Market Research Worth It?

Some businesses are just lucky to manage their performance without opting for market research, but these incidences are rare. Having information on longer sample sizes helps companies to eliminate bias and assumptions. As a result, entrepreneurs can make better decisions from the outset. In-Vitro Diagnostic Market report allows business to reduce their risks by offering a closer picture of consumer behavior, competition landscape, leading tactics, and risk management.

A trusted market researcher can guide you to not only avoid pitfalls but also help you devise production, marketing, and distribution tactics. With the right research methodologies, The Insight Partners is helping brands unlock revenue opportunities in the In-Vitro Diagnostic market.

If your business falls under any of these categories – Manufacturer, Supplier, Retailer, or Distributor, this syndicated In-Vitro Diagnostic market research has all that you need.

What are Key Offerings Under this In-Vitro Diagnostic Market Research?

Global In-Vitro Diagnostic market summary, current and future In-Vitro Diagnostic market size

Market Competition in Terms of Key Market Players, their Revenue, and their Share

Economic Impact on the Industry

Production, Revenue (value), Price Trend

Cost Investigation and Consumer Insights

Industrial Chain, Raw Material Sourcing Strategy, and Downstream Buyers

Production, Revenue (Value) by Geographical Segmentation

Marketing Strategy Comprehension, Distributors and Traders

Global In-Vitro Diagnostic Market Forecast

Study on Market Research Factors

Who are the Major Market Players in the In-Vitro Diagnostic Market?

In-Vitro Diagnostic market is all set to accommodate more companies and is foreseen to intensify market competition in coming years. Companies focus on consistent new launches and regional expansion can be outlined as dominant tactics. In-Vitro Diagnostic market giants have widespread reach which has favored them with a wide consumer base and subsequently increased their In-Vitro Diagnostic market share.

Report Attributes

Details

Segmental Coverage

Product & Service

Reagents & Kits

Instruments

Software & Services

Technology

Immunoassay/ Immunochemistry

Clinical Chemistry

Molecular Diagnostics

Microbiology

Blood Glucose Self-Monitoring

Coagulation Hemostasis

Hematology

Urinalysis

Others

Application

Infectious Diseases

Diabetes

Oncology

Cardiology

Autoimmune Diseases

Nephrology

Others

End User

North America

Europe

Asia Pacific

the Middle East & Africa

South & Central America

and Geography

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

Abbott Laboratories?

F. Hoffmann-La Roche Ltd?

Danaher Corp?

Siemens AG?

Sysmex Corp?

Thermo Fisher Scientific Inc

Becton Dickinson and Co

bioMerieux SA?

Bio-Rad Laboratories Inc

Qiagen NV

Other key companies

What are Perks for Buyers?

The research will guide you in decisions and technology trends to adopt in the projected period.

Take effective In-Vitro Diagnostic market growth decisions and stay ahead of competitors

Improve product/services and marketing strategies.

Unlock suitable market entry tactics and ways to sustain in the market

Knowing market players can help you in planning future mergers and acquisitions

Visual representation of data by our team makes it easier to interpret and present the data further to investors, and your other stakeholders.

Do We Offer Customized Insights? Yes, We Do!

The The Insight Partners offer customized insights based on the client’s requirements. The following are some customizations our clients frequently ask for:

The In-Vitro Diagnostic market report can be customized based on specific regions/countries as per the intention of the business

The report production was facilitated as per the need and following the expected time frame

Insights and chapters tailored as per your requirements.

Depending on the preferences we may also accommodate changes in the current scope.

Author’s Bio:

Sunil Jadhav

Senior Market Research Expert at The Insight Partners

0 notes

delvenservices · 1 year ago

Text

Rapid Diagnostics Market Size, Share & Forecast: 2028

Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Market Overview:

The Rapid Diagnostics market size is projected to reach a CAGR of 11.6% from 2022 to 2028.

Rapid Diagnostics are the medical techniques which are used for the diagnosis and the detection of the disease but are way to perform and are quick. These techniques play major role in the situation wherein the preliminary or the emergency situation similar to the ongoing pandemic. These test kits tend to provide the results in either 20 minutes or the same day.

The technological advancements in the sector along with the surge in the incidents of the infectious disease are some of the factors that have supported long-term expansion for Rapid Diagnostics Market.

COVID-19 had a positive effect on the market, as because the global demand has increased to various folds and also the shortage of lab-based testing facilities the demand for rapid diagnostics was increased.

Request Research Sample Pages: https://www.delvens.com/get-free-sample/rapid-diagnostics-market-trends-forecast-till-2028

Regional Analysis

North America is the most rapidly growing market and offers a huge opportunity for the industry, whose growth is driven by the incidents of lifestyle disorder becoming popular in the region and also the presence of the key players in the region.

Competitive Landscape

Key Players

Roche Diagnostics

Siemens Healthineers

Danaher Corporation

Becton Dickinson and Company

Abbott Laboratories

Quidel Diagnostics

Chembio Diagnostics

EKF Diagnostics

Trinity Biotech

Fluxergy

Recent Developments

In June 2019, FDA gave the approval to Roche diagnostics for VENTANA PD-L1 (SP142) Assay.

Make an Inquiry Before the Purchase: https://www.delvens.com/Inquire-before-buying/rapid-diagnostics-market-trends-forecast-till-2028

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for Rapid Diagnostics Market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

Rapid Diagnostics Market is segmented into product, platform, mode of purchase, end users and region.

On the basis of Product

Glucose Monitoring Products

Cardiometabolic Monitoring Products

Infectious Disease Testing Products

Coagulation Monitoring Products

Pregnancy & Fertility Testing Products

Fecal Occult Testing Products

Hematology Testing Products

Tumor/Cancer Marker Testing Products

Urinalysis Testing Products

Drugs-of-abuse Testing Products

Cholesterol Testing Products

Other POC Products

On the basis of Purchase

OTC Testing Products

Prescription-based Testing Products

On the basis of End-Users

Outpatient & Ambulatory Care Facilities

Hospitals & Critical Care Centers

Home Care Settings 5

Other End Users

On the basis of Region

Asia Pacific

North America

Europe

South America

Middle East & Africa

Purchase the Research Report: https://www.delvens.com/checkout/rapid-diagnostics-market-trends-forecast-till-2028

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Browse For More Related Reports:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

[email protected]

0 notes

ken-research-market-research · 6 years ago

Photo

Landscape Of The Global Point Care Diagnostics Market Outlook: Ken Research Buy Now The point-of-care diagnostic test is a medical diagnostic test accompanied outside the laboratory at or near the place where the patient is accepting the care and also defined as bedside testing or near-patient testing.

0 notes

jackssresearch · 2 years ago

Text

Home Healthcare Devices Market Size, Key Players, Industry Segments, Development, Opportunities, Forecast till 2026

Home Healthcare Devices Market Summary 2022-2030

Straits Research's latest report on, Home Healthcare Devices Market - Global Industry Overview and Forecast 2022-2030, highlights potential, risk factor Analyzes, and enhanced with strategic and tactical decision-making assistance. The growth and regulatory factors impacting information consumption, the availability of highly dependable items in the market, and the improvement in operating efficiency of Home Healthcare Devices industry players. The global home healthcare market was valued around USD 250.56 billion in 2017 and expected to register CAGR of 11.9% in the forecast period. Home Healthcare Devices Market Size covers market trends and development, drivers, capacities, technologies, and the changing dynamics of the Home Healthcare Devices Market.

Competitive Landscape

Some of the prominent players operating in the Home Healthcare Devices market are Philips Healthcare (Netherlands), Almost Family Inc. (US), Kindred Healthcare (US), Linde Group (Germany), A&D (Japan), Amedisys (US), Fresenius (Germany), LHC Group (US), Omron (Japan), McKesson (US), BAYADA Home Health Care (US), Kinnser Software, Inc. (US), Abbott Laboratories (US), and Roche (Switzerland).

Request a Sample Report for Free @ Home Healthcare Devices Market Size 2022-2030

Studies explore the effects of COVID-19 on the upstream, midstream, and downstream sectors of the industry. In addition, this analysis provides extensive market estimations by putting an emphasis on data covering numerous factors that encompass market dynamics such as market drivers, market barriers, market opportunities, market risks, and industry news and trends.

This research also provides a dashboard view of prominent organizations highlighting their effective marketing tactics, market share and most recent advances in both historical and current settings.

Global Home Healthcare Devices Market: Segmentation

As a result of the Home Healthcare Devices market segmentation, the market is divided into sub-segments based on product type, application, as well as regional and country-level forecasts. By Product, Testing, Screening, and Monitoring, Blood Pressure Monitors, Blood Glucose Monitors, Pulse Oximeters, Peak Flow Meters, Heart Rate Monitors, Fetal Monitoring Devices, HIV Test Kits, Sleep Apnea Monitors, Coagulation Monitors, Ovulation and Pregnancy Test Kits, Holter and Event Monitors, Cholesterol Monitoring Devices, Colon Cancer Test Kits, Home Hemoglobin A1c Test Kits, Drug and Alcohol Test Kits, ECG/EKG Devices, EEG Devices, Temperature Monitors, Hearing Aids, Pedometers, Therapeutic, Oxygen Delivery Systems, Nebulizers, Ventilators, Sleep Apnea Therapeutic Devices, Wound Care Products, IV Equipment, Dialysis Equipment, Insulin Delivery Devices, Inhalers, Other Therapeutic Products (Ostomy Devices, Automated External Defibrillators, and External Stimulation Devices), Mobility Care, Canes, Crutches, Mobility Scooters, Walkers and Rollators, Wheelchairs By Service, Rehabilitation, Infusion Therapy, Unskilled Care, Respiratory Therapy, Pregnancy Care, Skilled Nursing, Hospice and Palliative Care By Software, Agency Software, Clinical Management Systems, Hospice Solutions By Type, Home Telehealth Monitoring Devices, Home Telehealth Services, Telehealth Software Solutions

The report forecasts revenue growth at all the geographic levels and provides an in-depth analysis of the latest industry trends and development patterns from 2020 to 2030 in each of the segments and sub-segments. Some of the major geographies included in the market are given below:

North America (U.S., Canada)

Europe (U.K., Germany, France, Italy)

Asia Pacific (China, India, Japan, Singapore, Malaysia)

Latin America (Brazil, Mexico)

Middle East & Africa

You may buy this document on Buy Home Healthcare Devices Market Report

The following are the report's key features:

It gives useful information on the Global Home Healthcare Devices Market.

Information for the years 2022-2030 is provided.

Market-related important factors are highlighted.

The latest technological innovations, government restrictions, and developments are presented.

This paper investigates advertising and marketing techniques, market trends, and analysis.

Growth projections and Analyzes by forecast 2030.

The statistical analysis of the market's leading competitors is Emphasize.

Home Healthcare Devices Market summary based on extensive study.

Other aspects of the report include:

Provides a complete review of important tactics in numerous firms, with an emphasis on corporate structure, R&D processes, localization strategies, manufacturing capabilities, sales, and performance.

Provides essential product portfolio information, including product planning, development, and positioning.

Analyzes the role of significant market participants, as well as their collaborations, mergers, and acquisitions.

The Table of Contents and Figures of the Full Report are available for your perusal Home Healthcare Devices Market Report with TOC

Trending Report:

https://www.marketwatch.com/press-release/assisted-reproductive-technology-industry-segmentation-by-top-market-players-bloom-ivf-centre-ovascience-california-cryobank-2022-06-14 https://www.marketwatch.com/press-release/resin-capsule-market-size-share-trends-by-forecast-2026-top-prominant-payers-sika-ag-switzerland-orica-limited-australia-barnes-group-us-2022-06-14 https://www.marketwatch.com/press-release/silica-cat-litter-industry-outlook-and-forecast-by-2026-top-market-players-nestle-purina-petcare-company-the-clorox-company-2022-06-15

About Us:

StraitsResearch.com is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.

Contact Us: Email: [email protected] Address: 825 3rd Avenue, New York, NY, USA, 10022 Tel: +1 6464807505, +44 203 318 2846 Website: https://straitsresearch.com/

0 notes

mrfrblogresearch02 · 3 years ago

Text

Point of Care Diagnostics/Testing Market Size Analysis, Research Study 2027

Point of Care Diagnostics Market -Overview:

According to MRFR analysis, the global Point of Care Diagnostics Market Size is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.

The medical equipment utilized to get an immediate result in examining various diseases, diabetes, cancer, heart diseases, are defined as point of care (POC) diagnostics. These devices include glucose monitoring kits, infectious disease testing kits, pregnancy and fertility testing kits, and drug abuse testing kits, to name a few.

The tests can be employed in a variety of circumstances, with each requiring a different course of action depending on the outcome. The drug screening kit can be used for several different purposes. In general, the test is used to determine whether or not a person has consumed any narcotic substance. Sportsmen and women can take the test to ensure that no narcotic substances are present before competing. The advent of portable POC devices supporting government policies is supplementing the POC diagnostics/testing market, with an increasing number of chronic conditions such as diabetes around the globe and a relatively small number of healthcare facilities in developing nations. In addition, market participants are introducing digital and wireless POC solutions to improve diagnosis efficiency and accuracy.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: The market for point-of-care diagnostics is dominated by North America (which includes the United States and Canada). With the rising incidence and prevalence of lifestyle diseases, North America is gaining traction. More awareness of self-testing and home care goods and a considerable adoption of novel technologies are projected to play a crucial role in driving the point-of-care diagnostics market in North America. Healthcare product providers are merging and acquiring current market participants to extend their product availability across the region. Lacuna Diagnostics (US), a company that provides digital cytology point of care and telehealth services, was bought by Heska Corporation (US).

Owing to the limited availability of healthcare workers, various manufacturing facilities, changing demographics, and increasing consumer healthcare expectations, the Asia-Pacific point of care diagnostics/testing market is expected to be the fastest-growing market sector. Furthermore, comforting government rules, significant funding by industry participants, and innovative technically advanced solutions are all elements boosting the point of care diagnostics/testing market.

Segmentation: The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.

Based on end user, the global point of care diagnostics/testing market has been classified as hospitals & clinics, diagnostics centers, homecare/self-testing, and others. Hospitals &clinics held the largest segment share in 2020, owing to easy maneuvering, sample processing, and quick delivery of results. A laboratory information system also manages and stores patient’s test data for further reference, which further drives the market growth. Additionally, the demand for homecare/self-testing is accelerating due to increasing health risks during the pandemic outbreak and rising connectivity between patients and health care providers.

Based on mode of purchase, the global point of care diagnostics/testing market has been classified as over-the-counter (OTC) testing products and prescription-based testing products. The OTC testing products aim to hold a larger market share in the mode of purchase category. OTC products are sold without the prescription for generic disease-diagnosed patients. Theycomply with certain parameters that include the highest standards for efficacy and safety, Good Manufacturing Practice (GMP) manufacturing, stability testing, and labeling under 21 CFR 201.66. According to the FDA, over 300,000 marketed OTC drug products are categorized into 80 therapeutic classes. The largevariety and availability of the products are driving the point of care diagnostics/testing market.

Based on the platform, the global point of care diagnostics/testing market has been classified as immunoassays, molecular diagnostics, dipstick, and others. Immunoassays is estimated to hold the largest segment share in 2020, owing to the increasing demand forthe products for testing particular antibodies or a specific antigen in blood or other body fluids. The immunoassays-based POC test is carried out in countries with low resources and facilities. Among the immunoassays, lateral flow immunoassays are highly used for quick diagnosis as they are sensitive to specific antigens and offer quick & accurate results.

Key Players:

Some of the key players in the global point of care diagnostics/testing market are Abbott Laboratories (US), Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), AccuBioTech Co., Ltd.(China), Instrumentation Laboratory Company (Werfen) (US), and EKF Diagnostics Holdings plc (UK) among others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

#Point of Care Diagnostics Testing Market

0 notes

itssashasharma · 3 years ago

Text

US Anticoagulation Therapy Market worth USD 27.83 Billion : Indicates Impressive Growth Rate In Pharmacy-based And Medical device Industry

The market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. The growth in the anticoagulation drugs market is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs). On the other hand, the high cost of NOACs and requirement of significant investments in the development of anticoagulation drugs are the major factors restraining the growth of this market.

According to a new market research report “US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) – Forecast to 2022“, published by MarketsandMarkets™, the market has witnessed a healthy growth rate during the last decade and is expected to grow at a CAGR of 8.5% between 2017 and 2022 to reach USD 27.83 Billion by 2022.

Browse in-depth TOC on “US Anticoagulation Therapy Market“

29 Tables 25 Figures 86 Pages

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=114158575

Factors such as the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs) is driving the growth of this market.

The NOACs segment accounted for the largest share of the US Anticoagulation Therapy Market for drugs in 2016

The US anticoagulation drugs market is categorized into NOACs, warfarin (VKA), and other drugs. In 2016, the NOACs segment accounted for the largest share of the market. Due to the better safety and efficacy of NOACs as compared to traditional therapies, the adoption of NOACs is higher as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC Betrixaban in July 2017) are focusing on the development of NOACs in order to capitalize on the growth opportunities presented by this shift in market dynamics. Consequently, many other companies are also expected to focus on developing more safe and efficient NOACs in the coming years; this will ensure the continued growth of this segment.

The in-office testing devices accounted for the largest share of the US Anticoagulation Therapy Market for PT/INR testing devices in 2016

The global US Anticoagulation Therapy Market for PT/INR testing devices is segmented into in-office testing devices and home testing devices. In 2016, the in-office testing devices segment dominated the US Anticoagulation Therapy Market for PT/INR testing devices. The large share of this segment is mainly attributed to the large number of patients opting for in-office testing services. However, the home testing devices segment is expected to grow at the highest CAGR due to its advantages such as convenience, time & cost savings, and quick result generation. Additionally, the cost of test devices and the tests themselves are often reimbursable.

By type of service, the testing services held the largest market share of the anticoagulation therapy market for clinics in 2016

On the basis of types of services provided, the US Anticoagulation Therapy Market for clinics is categorized into testing services and consulting services. In 2016, the testing services segment accounted for the largest share of the US Anticoagulation Therapy Market for clinics. The recurring need for PT/INR monitoring is the key factor driving the growth of this market. However, the shift of patients toward novel anticoagulant agents and high adoption of home testing devices are expected to restrain the growth of this market to a certain extent

By type of clinics, hospital associated clinics held the largest market share of the anticoagulation therapy market for clinics in 2016

On the basis of type of clinics, the US Anticoagulation Therapy Market for clinics is categorized into hospital associated clinics, independent clinics, and pharmacy-based clinics. In 2016, the hospital associated clinics segment accounted for the largest share of the US Anticoagulation Therapy Market for clinics.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=114158575

C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US Anticoagulation Therapy Market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US Anticoagulation Therapy Market for PT/INR home testing devices.

Browse Related Reports

Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) – Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/hemostasis-coagulation-analyzer-market-197226392.html

Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based – Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Rohan MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected]

0 notes

leonfrancisblog · 3 years ago

Text

Europe POCT Device Market to Witness CAGR of 8.6% in the Forecast Period of 2020 to 2027|Key Players Abbott Laboratories, Inc., Alere Inc., roche Diagnostics Limited, Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc.

POCT device market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 6.3 Billion in 2019 growing at a CAGR of 8.8% in the above-mentioned forecast period. The rise of infectious diseases across Europe requires early detection and diagnosis of infectious diseases in the region. Point-of-care testing (POCT) is an important part of the clinical diagnosis market and is rapidly evolving into a preferred test mode as infection, diagnosis leads to lower antibiotic intake, lower laboratory tests for patients, and lower treatment costs. This is not only cost effective for patients but also for hospitals.

The results of diagnostic test take few hours to days that totally depend on the type of disease. Rapid diagnosis is important for survivors. The new regulations, reimbursement laws and technological advancements all focus on making the test accurate, operationally efficient, portable and easy to use. Increasing the scope of POCT equipment, advancements in technology, increased incidence of chronic diseases, increased demand for self-test point care test equipment, decentralized laboratory testing and microscopic laboratory are some of the key factors driving the market. Many market players are constantly trying and updating upcoming products with more up-to-date innovations in portable devices with lower sample volume or less blood to get more success in in-vitro diagnosis related company, which is creating opportunities for the market players. The growing cost of POCT equipment is one of the factors that are hindering the growth of this market.

Europe POCT Device Market, By Product Type (Blood Glucose Testing Kits, Cardio Metabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy and Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing kits, and Others), Prescription (Prescription Based Testing and Over-The-Counter (OTC) Testing), Distribution Channel (Direct Tenders and Retail), End users (Hospital, Clinics, Ambulatory Care, Home Healthcare, and Research Laboratory), Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe) Industry Trends and Forecast to 2027 This Europe POCT device market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research Europe POCT device market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Get More Info Sample Request on Europe POCT Device Market,@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-poct-device-market

Europe POCT Device Market Scope and Market Size:

Europe POCT device market is segmented on the basis of product type, prescription mode, distribution channel, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insight s to help them in making strategic decisions for identification of core market applications.

Based on product type, the Europe POCT device market is segmented into blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others. Cardiometabolic monitoring kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections and respiratory infections testing kit. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.

On the basis of prescription mode, the Europe POCT device market is segmented into prescription based testing and over-the-counter (OTC) testing. On the basis of distribution channel, the Europe POCT device market is segmented into direct tenders and retail. On the basis of end users, the Europe POCT device market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others. Others are further segmented into intensive care unit, neo-natal.

Key Market Competitors:

The major players covered in the Europe POCT device market report Abbott Laboratories, Inc., Alere Inc., roche Diagnostics Limited, Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

MAJOR TOC OF THE REPORT:

Chapter One: Europe POCT Device Market

Chapter Two: Manufacturers Profiles

Chapter Three: Europe POCT Device Market Competition, by Players

Chapter Four: Europe POCT Device Market Size by Regions

Chapter Five: Europe POCT Device Market Revenue by Countries

Chapter Six: Europe POCT Device Market Revenue by Type

Chapter Seven: Europe POCT Device Market Revenue by Application

Chapter Eight: Europe POCT Device Market Revenue by Industries

Chapter Nine: Europe POCT Device Market Revenue by Deployment Model

Chapter Ten: Europe POCT Device Market Revenue by End User

Get Table of Content on Request @ https://www.databridgemarketresearch.com/toc/?dbmr=europe-poct-device-market

Reasons for buying this Europe POCT Device Market:

Laser Capture Europe POCT Device Market aids in understanding the crucial product segments and their perspective.

Initial graphics and exemplified that a SWOT evaluation of large sections supplied from the Laser Capture Europe POCT Device Market.

Even the Laser Capture Europe POCT Device Market economy provides pin line evaluation of changing competition dynamics and retains you facing opponents.

This report provides a more rapid standpoint on various driving facets or controlling Medical Robotic System promote advantage.

This worldwide Locomotive report provides a pinpoint test for shifting dynamics that are competitive.

The key questions answered in this report:

What will be the Market Size and Growth Rate in the forecast year?

What is the Key Factors driving Laser Europe POCT Device Market?

What are the Risks and Challenges in front of the market?

Who are the Key Vendors in Europe POCT Device Market?

What are the Trending Factors influencing the market shares?

What is the Key Outcomes of Porter’s five forces model

Access Full Report https://www.databridgemarketresearch.com/reports/europe-poct-device-market

Browse Related Report:

Vascular Closure Device Market

Refurbished Medical Device Market

Surgical Staplers Device Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

#Market by Type Market Development Market Forecast Market Size Future Innovation Market Future Trends Market Share Market Demand Market Growt

0 notes

industryjournals · 5 years ago

Text

Home Healthcare Market 2019 Share and Forecast to 2026: American Well, CarePredict,

The latest research on the Home Healthcare market fundamentally delivers insights that can empower stakeholders, business owners, and field marketing executives to make effective investment decisions driven by facts and extremely thorough research. The study aims to provide an evaluation and deliver essential information on the competitive landscape to meet the unique requirements of the companies and individuals operating in the Home Healthcare market for the forecast period, 2019–2026. To help firms comprehend the Home Healthcare industry in multiple ways, the report exhaustively assesses the share, size, and growth rate of the business worldwide.

Market Size- USD 260.95 Billion in 2018, Market Growth- CAGR of 7.9%, Market trends- rise in chronic diseases worldwide is boosting the global home healthcare market, Asia Pacific expected to register the highest CAGR during the forecast period

To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://www.reportsanddata.com/sample-enquiry-form/2025

The market intelligence report gives a concise view of various consumer groups functional in the industry and their need to help product owners cater to those requirements and generate profit. Apart from this, the report aims at outlining the consumers whom business owners operating in the Home Healthcare market should and should not target, along with the main alternatives and competitive product offerings. Defining major challenges and roadblocks remains the key focus of the study. Problem definition covered in the report provides a systematic approach to recent investments and makes product marketing both simpler and more efficient.

In market segmentation by manufacturers, the report covers the following companies-

American Well (USA), CarePredict (USA), Emerald (USA), A&D (Japan), Philips Healthcare (Netherlands), Roche (Switzerland), Omron (Japan)

For the purpose of this study, Reports and Data have segmented the Home Healthcare market by Type, by Services, by Product, by Software and by Region:

Type

Home Telehealth Monitoring

Home Telehealth Services

Telehealth Software Solutions

Services

Rehabilitation

Infusion Therapy

Unskilled Care

Respiratory Therapy

Pregnancy Care

Skilled Nursing

Telemetry

Hospice and Palliative Care

Go through our meticulously drafted TOC, Tables, Statistics, Charts, and Company profiles: -https://www.reportsanddata.com/report-detail/home-healthcare-market

Product

Diagnostic (Blood Glucose Monitors, Blood Pressure Monitors, Pulse Oximeters, Peak Flow Meters, Heart Rate Monitors, Fetal Monitoring Devices, HIV Test Kits, Sleep Apnea Monitors, Coagulation Monitors, Ovulation and Pregnancy Test Kits, Holter and Event Monitors, Cholesterol Monitoring Devices, Colon Cancer Test Kits, Home Hemoglobin A1c Test Kits, Drug and Alcohol Test Kits, ECG/EKG Devices, EEG Devices, Temperature Monitors, Hearing Aids, Pedometers)

Therapeutic (Oxygen Delivery Systems, Nebulizers, Ventilators, Sleep Apnea Therapeutic Devices, Wound Care Products, IV Equipment, Dialysis Equipment, Insulin Delivery Devices, Inhalers, Other Therapeutic Products)

Mobility Care (Canes, Crutches, Mobility Scooters, Walkers & Rollators, Wheelchairs)

Software

Agency Software

Clinical Management Systems

Hospice Solutions

Region

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

The report charts the future of the Home Healthcare market for the forecast years from 2019 to 2026. The perfect balance of information on various topics, coupled with the sudden rise in the levels of disposable income, end-use, distribution channels, and other factors add great value to this literature. A combination of charts, graphics images, and tables offers more clarity on the overall study. Researchers behind the report also explore the customers’ interest in purchasing products and services from immediate industry rivals.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-home-healthcare-market

There are 11 chapters to cover the vital aspects of the Global Home Healthcare Market.

Chapter 1 covers the Home Healthcare Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2 talks about the top manufacturers and analyzes their sales, revenue and financial strategies for the years 2018 and 2019;

Chapter 3 scrutinizes the competitive nature of the market by discussing the competition among the top manufacturers. It classifies the market by referring to sales, revenue, and market share data for 2016 and 2017;

Chapter 4, shows the global market by geographical regions and the contribution of each region to the global landscape based on sales, revenue and market share of Home Healthcare, for the period 2019-2026;

Continue...

About Us: Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Contact Us: John Watson Head of Business Development Direct Line: +1-212-710-1370 E-mail: [email protected] Reports and Data | Web: www.reportsanddata.com

#Home Healthcare Market Trends #Home Healthcare Market Application #Home Healthcare Market Share #Home Healthcare Market Outlook #Home Healthcare Market Overview #Home Healthcare Market Analysis #Reports and Data #Home Healthcare Market Size #Home Healthcare Market vendors

0 notes

usa-consulting-news-blog · 5 years ago

Text

Home Healthcare Market Is Expected To Grow Rapidly By 2026 | Top Key Players - American Well (USA), CarePredict (USA), Emerald (USA), A&D (Japan), And More.

The report studies Home Healthcare in Global market Professional Survey 2019: Industry Trends, Industry Growth, Size, Share, Drivers, Restraints, Opportunities, Production, Segmentation, Pricing, Value, Volume, Company Profiling, Competitive Landscape, Product Portfolio, and Specifications for the Forecast Period till 2026.

This market intelligence study curates an exhaustive database of industrial essentials for formulating favorable strategies. A thorough investigation of the value chain and the distribution channel is provided in this study by business professionals. The Home Healthcare Market study offers detailed information pertaining to the extent and application of the market, which helps better understand the global sector. This report on the Global Home Healthcare Market discusses several growth prospects, including the industry sectors, current trends, up-to-date outlines, driving factors, and hurdles, overall offering market projections for the coming years.

Get Access to Report Sample: https://www.reportsanddata.com/sample-enquiry-form/2025

Major Key Players of the Home Healthcare Market are:

American Well (USA), CarePredict (USA), Emerald (USA), A&D (Japan), Philips Healthcare (Netherlands), Roche (Switzerland), Omron (Japan)

For the purpose of this study, Reports and Data have segmented the Home Healthcare market by Type, by Services, by Product, by Software and by Region:

Type

Home Telehealth Monitoring

Home Telehealth Services

Telehealth Software Solutions

Services

Rehabilitation

Infusion Therapy

Unskilled Care

Respiratory Therapy

Pregnancy Care

Skilled Nursing

Telemetry

Hospice and Palliative Care

Product

Blood Glucose Monitors

Blood Pressure Monitors

Pulse Oximeters

Peak Flow Meters

Heart Rate Monitors

Fetal Monitoring Devices

HIV Test Kits

Sleep Apnea Monitors

Coagulation Monitors

Ovulation and Pregnancy Test Kits

Holter and Event Monitors

Cholesterol Monitoring Devices

Colon Cancer Test Kits

Home Hemoglobin A1c Test Kits

Drug and Alcohol Test Kits

ECG/EKG Devices

EEG Devices

Temperature Monitors

Hearing Aids

Pedometers

Oxygen Delivery Systems

Nebulizers

Ventilators

Sleep Apnea Therapeutic Devices

Wound Care Products

IV Equipment

Dialysis Equipment

Insulin Delivery Devices

Inhalers

Other Therapeutic Products

Canes

Crutches

Mobility Scooters

Walkers & Rollators

Wheelchairs

Software

Agency Software

Clinical Management Systems

Hospice Solutions

Region

Canada

Germany

France

Spain

Italy

Rest of the Europe

China

India

Japan

Rest of Asia-Pacific

Brazil

The Home Healthcare market is heavily consolidated owing to a large number of global, regional, and local key contenders having already established a significant footing. The key participants dominate the operations in the industry with their extensive geographical coverage and huge production facilities. Players operating in this market are in intense competition in terms of technological innovations, product development, and product pricing. To gain a competitive edge over the other competitors in the Home Healthcare industry, the leading players are focusing more on ways to offer products at attractive prices.

Get Discount on this Report: https://www.reportsanddata.com/discount-enquiry-form/2025

Regional Home Healthcare Market (Regional Output, Demand & Forecast by Countries):-

North America (United States, Canada, Mexico)

South America (Brazil, Argentina, Ecuador, Chile)

Asia Pacific (China, Japan, India, Korea)

Europe (Germany, UK, France, Italy)

Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and More.

What are the market factors that are explained in the report?

Market dynamics: The Home Healthcare5 report also assesses the various commercial possibilities that are expected to be revealed in the near future and the positive revenue forecasts in the years ahead. It also studies the key markets and explores different geographies where the industry is established.

Competitive Market Share: The key players focus their operations in the sector in select regions, owing to their robust geographic reach and huge production facilities. Players operating in this market are in intense competition in terms of technological advancements, product development, and product pricing. To gain a competitive upper hand over the other rivals in the Home Healthcare industry, the prominent players are focusing more on offering products at reasonable prices.

The Goal of The Report: The main objective of this research study is to provide a holistic overview and a better interpretation of market aspects to producers, suppliers, and distributors. The readers can get profound insights into this market that will allow them to formulate and develop critical strategies to bring about the desired business expansion.

Feature of the report:

The report studies the key factors affecting the market:

The various opportunities in the market.

To study the overall size of the market and deduce industry trends from this analysis.

To inspect the market based on the product, market share, and product share.

To analyze the market on the basis of end-users and applications focused on the growth rate of each application segment.

View Full Report Description with TOC: https://www.reportsanddata.com/report-detail/home-healthcare-market

Reasons to Purchase Home Healthcare Market Report:

Current and future progression of Home Healthcare products in the developed and emerging markets.

The segments that are estimated to control the future growth of the Home Healthcare market.

Regions that are expected to undergo the fastest growth during the forecast years.

Identify the recent developments, Home Healthcare market shares, and lucrative strategies deployed by the prominent market contenders.

Moreover, the research report mentions the leading players in the global Home Healthcare market. Their critical marketing approaches and advertising enterprise have been underlined to offer a clear outlook of the Home Healthcare market.

#Home Healthcare Market

0 notes

omgsampada · 4 years ago

Link

According to a new study published by Polaris Market Research the global point of care (PoC) diagnostics market is anticipated to reach USD 34.6 billion by 2025.

Point of Care (PoC) diagnostics, are medical devices or tools that helps to diagnose the disease in patient’s community, usually outside of clinical labs. The point of care allows earlier diagnostics of disease and to improve the health status of patients. The point of care diagnostics can help to save patient’s expenses by early and accurate diagnosis of disease, and by reducing unnecessary travel to clinic.

The point of care diagnostics helps to improve early and correct detection of disease. The point of care diagnostics is composed of approved tests that are carried out near the patient and self-test/at home (over the counter). The point of care diagnostics test requires few seconds for the result and do not require permanent dedicated space in a clinical laboratory. The point of care diagnostics test includes small labs near ICUs at hospitals that perform rapid tests.

Increasing incidences of chronic diseases such as cancer, diabetes, along with rising awareness for early disease diagnosis is expected to drive the growth of point of care diagnostics market are key factors responsible for the growth of point of care diagnostics market globally. Moreover, growing research and development expenditure by top players of the point of care diagnostics market is expected to fuel the growth of the global market. However, high expenditure for product development and stringent regulatory environment may hamper the growth of market.

Request for a sample of this research report @https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-sample

The global Point of Care (PoC) Diagnostics market is segmented on the basis of product type, mode of prescription, end user, and by region. By product type, the global Point of Care (PoC) diagnostics market is further segmented into cardio metabolic monitoring kits, infectious disease testing kits, glucose monitoring kits, coagulation monitoring kits, pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, cholesterol test strips, drugs-of-abuse testing kits, fecal occult testing kits, and other point of care testing kits. The infectious disease segment by product type in the global point of care diagnostics market is estimated to grow at high pace during the forecast period. The rising prevalence of infectious diseases such as AIDS and HIV globally is expected to propel the growth of segment in the global point of care diagnostics market.

By end user, the global Point of Care (PoC) Diagnostics market is further segmented into professional diagnostics centers, research laboratories home care settings, nd others. On the basis of end user, the professional diagnostics segment accounted major share in the global point of care diagnostics market. The professional diagnostics centers segment comprises outpatient healthcare settings, hospitals, and ambulatory care centers. The home care settings segment by end user is estimated to grow at high CAGR during the forecast period. The increasing demand for diagnostics tools are home is expected to propel the growth of global point of care diagnostics test market globally.

The key players operating in global Point of Care (PoC) diagnostics market includes Abbott Laboratories, Inc., Roche Diagnostics, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, bioMerieux, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics, and Nova Biomedical among others. The increasing investment in research and development activities across the top players is expected to propel the growth of market in the global point of care diagnostics market.

Get Exclusive Discount on This Report @ https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavour to deliver value-added business solutions to our customers.

Polaris Market Research

Phone: 1-646-568-9980

Email: [email protected]

Web: www.polarismarketresearch.com

0 notes

mrfrblogresearch02 · 3 years ago

Text

Point of Care Diagnostics/Testing Market Demand, Cost Analysis And Latest Advancement in Medical Sector 2027

Market Highlights:

According to MRFR analysis, the global point of care diagnostics/testing Market Size is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.

The global point of care diagnostics/testing market is driven by several factors, such as increasing demand for remote diagnosis, rising demand for early-stage diagnosis products, and growing demand for minimally or non-invasive diagnostic products. Other factors such as the introduction of mobile healthcare technologies and wearable diagnostic devices, the emergence of new technologies for monitoring and imaging are creating opportunities for the market players.

The market players are involved in various strategic collaborations, mergers & acquisitions, product launches, cooperative development of the product, and investing in stock to expand their worldwide presence. For instance, in July 2020, Becton, Dickinson and Company (US) launched a rapid POC antigen test to diagnose SARS-CoV-2 in 15 minutes. In June 2020, Celltrion Group (South Korea) announced to launch COVID-19 POC antigen testing kit. Furthermore, the prominent players focus on employee satisfaction, transforming their research utilities, and diversifying their distribution network. These factors will augment the market growth and will increase the market share during the forecast period. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: North America is estimated to dominate the point of care diagnostics/testing market, owing to the increasing demand for virtual and convenient diagnostic solutions, enhancement in healthcare regulations, and growing awareness about wellness and healthcare among the young population. Furthermore, the involvement/adoption of strategies like mergers & acquisitions by key players, government partnerships, and the development of new products are also propelling the market growth. Europe embraces the second-largest position in the point of care diagnostics/testing market due to the increasing number of IVD testing, molecular diagnostics, and the prevalence of respiratory diseases across the region. The industry players are involved in various business activities such as product launches, mergers and acquisitions, partnerships, and other commercial approaches. For instance, in May 2020, ProciseDx (US) launched 510k filing for CRP test in Europe for gastrointestinal disorders. The product launch aims to offer high lab-quality results to the patients. In addition, in July 2021, QuantuMDx (Singapore) launched Q-POC, a point-of-care diagnostics to detect SARS-CoV-2. The product is easy to use, affordable, and offers results in 30 minutes. Such business parameters are expected to propel the point of care diagnostic market in the forecast period.

Asia-Pacific is projected to be the fastest-growing regional market during the study period due to increasing demand for diagnostic tests such as blood gas tests, rapid blood coagulation tests, pregnancy tests, drug abuse screening, rapid diagnosis of cardiac markers, blood glucose testing, electrolyte analysis, urine analysis, and dry biochemical tests across the region. In addition, the increasing demand for multiple diagnostic devices coupled with the rising demand for accurate and efficient diagnostic and testing devices is driving the Asia-Pacific point of care diagnostics market.

The growth of the market in the Rest of the World is gaining importance over the last few years due to the increasing diagnosis of HbA1c and growing demand for glycated hemoglobin analysis. Moreover, the rising number of COVID-19 cases across the region is supporting the demand for POCs diagnosis. In addition, increasing investment in healthcare device manufacturing facilities is strengthening the product portfolio of the regional and global healthcare providers. The escalating demand for in-vitro diagnostics in South America is fueling the sales of POCs across the region. Such factors are expected to augment the market growth over the assessment period.

Segmentation:

The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.

Key Players:

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642

About Market Research Future:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

#Point of Care Diagnostics/Testing Market #Point of Care Diagnostics/Testing Market trend #Point of Care Diagnostics/Testing Market analysis #Point of Care Diagnostics/Testing Market share

0 notes

leonfrancisblog · 4 years ago

Text

Europe POCT Device Market Industry Analysis Size, Share, Trends and Profitable Segments Breakdown and Detailed Analysis of Current and Future Industry Figures till 2027 |Key Players Abbott Laboratories, Inc., Alere Inc., roche Diagnostics Limited, Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc.

POCT device market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research Europe POCT device market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. Europe POCT device market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 6.3 Billion in 2019 growing at a CAGR of 8.8% in the above-mentioned forecast period. The rise of infectious diseases across Europe requires early detection and diagnosis of infectious diseases in the region. Point-of-care testing (POCT) is an important part of the clinical diagnosis market and is rapidly evolving into a preferred test mode as infection, diagnosis leads to lower antibiotic intake, lower laboratory tests for patients, and lower treatment costs. This is not only cost effective for patients but also for hospitals.

Europe POCT Device Market, By Product Type (Blood Glucose Testing Kits, Cardio Metabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy and Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing kits, and Others), Prescription (Prescription Based Testing and Over-The-Counter (OTC) Testing), Distribution Channel (Direct Tenders and Retail), End users (Hospital, Clinics, Ambulatory Care, Home Healthcare, and Research Laboratory), Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe) Industry Trends and Forecast to 2027Europe POCT device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for Europe POCT device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe POCT device market. The data is available for historic period 2010 to 2018.Competitive Landscape and Europe POCT Device Market Share Analysis. Europe POCT device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Europe POCT device market.

Get More Info Sample Request on Europe POCT Device Market,@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-poct-device-market

Europe POCT Device Market Country Level Analysis:

Europe POCT device market is analyzed and market size insights and trends are provided by country, product and end use as referenced above.

The country section of the Europe POCT device market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. The countries covered in the Europe POCT device market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and Rest of Europe in Europe.

Technavio market research analysts estimate the blood glucose testing segment to be the largest market segment during the forecast period. The high availability of devices like glucose monitoring systems and blood glucose meters in the European region is a key factor that fosters market growth in this segment during the forecasted period.

Europe POCT Device Market Scope and Market Size:

Customization Available: Europe POCT Device Market:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Get Table of Content on Request @ https://www.databridgemarketresearch.com/toc/?dbmr=europe-poct-device-market

Reasons for buying this Europe POCT Device Market:

Laser Capture Europe POCT Device Market aids in understanding the crucial product segments and their perspective.

Initial graphics and exemplified that a SWOT evaluation of large sections supplied from the Laser Capture Europe POCT Device Market.

Even the Laser Capture Europe POCT Device Market economy provides pin line evaluation of changing competition dynamics and retains you facing opponents.

This report provides a more rapid standpoint on various driving facets or controlling Medical Robotic System promote advantage.

This worldwide Locomotive report provides a pinpoint test for shifting dynamics that are competitive.

The key questions answered in this report:

What will be the Market Size and Growth Rate in the forecast year?

What is the Key Factors driving Laser Europe POCT Device Market?

What are the Risks and Challenges in front of the market?

Who are the Key Vendors in Europe POCT Device Market?

What are the Trending Factors influencing the market shares?

What is the Key Outcomes of Porter’s five forces model

Access Full Report https://www.databridgemarketresearch.com/reports/europe-poct-device-market

Browse Related Report:

Vascular Closure Device Market

Refurbished Medical Device Market

Surgical Staplers Device Market

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

#Market by Type Market Development Market Forecast Market Size Future Innovation Market Future Trends Market Share Market Demand Market Growt

0 notes

itsmadhurip3918world-blog · 6 years ago

Text

Europe In-vitro Diagnostics Market by 2024

Graphical Research presents a most up-to-date report on “Europe In-vitro Diagnostics Market analysis based on Product Type, Service Type, Technology, Application, End-User, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024”, Estimated to reach USD 21 billion by 2024

Improvement in healthcare infrastructure will drive Europe in-vitro diagnostics market growth. Majority of the population staying in developed countries rely on healthcare facilities developed by the public healthcare sector that has lower cost structure thereby will escalate demand for cost-effective diagnostic services augmenting industry growth. Also, key industry players such as Roche diagnostics, Beckman Coulter and others have inculcated advanced technology within the in-vitro diagnostic devices that are largely adopted by the doctors to treat various diseases at gene/molecular level should have positive impact on the in-vitro diagnostic industry growth.

Request for a sample of this research report - https://www.graphicalresearch.co...

Regulations implemented by the European Diagnostic Clusters Alliance (EDCA) has enforced specific guidelines for manufacturers of the in-vitro diagnostics tools and equipment to meet patient’s safety demand thereby will augment in-vitro diagnostic industry growth. The EDCA includes 350 companies and 46 universities that are focusing on continuous upgradation of technology within IVD devices should increase its adoption rates among the laboratories and hospitals thereby escalating the industry growth in forthcoming years. However, high costs associated with the in-vitro diagnostic tests will hamper the industry growth.

In-vitro diagnostic services segment held an enormous share of 78.9% in 2017 and is projected to grow significantly over the forecast timeframe as a result of growing geriatric population globally that will augment demand for in-vitro diagnostic services influencing the segmental growth positively.

In-vitro diagnostic instruments segment will grow at 4.9% during the forecast timeframe owing to increasing number of laboratories equipped with instruments of superior quality. According to Global Genes, more than 30 million people suffer from rare diseases in Europe that require critical monitoring and diagnosis at gene level that should escalate the demand for diagnostic instruments.

Immunoassays or immunochemistry segment was valued at USD 3.0 billion in 2017 and high growth can be accounted to various benefits offered by these tests. For instance, accurate, rapid and cost-effective services enabled by such assays are more reliable and improves performances of surgical procedures thereby will impact the industry growth positively in upcoming years. Immunoassays and biosensors are platforms integrated with lab-on-a-chip technology providing reliable results thereby will upsurge the in-vitro diagnostics industry growth.

Make an inquiry for purchasing this report @ https://www.graphicalresearch.co...

Cardiology segment will grow at 5.9% during the forecast timeline as a result of increasing incidence of cardiovascular diseases due to tobacco smoking, lack of physical activity, consumption of alcohol and unhealthy diet that will drive the segmental growth. Moreover, round 17.7 million people die every year due to CVD that should impact positively on the business growth.

Germany in-vitro diagnostics industry was valued at USD 2.1 billion in 2017 and is expected to grow exponentially over the estimated timeframe owing to the increasing number of technological advancements that are being incorporated in the medical diagnostic devices. For instance, major industry players such as Roche diagnostics have developed clinical diagnostic solutions and devices integrated with advanced technology enabling automation and increasing the operational efficiency that will thereby boost the preference for clinical chemistry, blood gas analysis and other such analytical devices that will stimulate the industry growth.

Laboratories segment held enormous revenue share of 29.4% in 2017 due to presence of various growth opportunities such as availability of skilled labor to work increasing the level of operational efficiency. High preference for laboratories with well-equipped diagnostic machines and equipment will thereby propel the segment growth.

Major industry competitors operating in Europe in-vitro diagnostics market are Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens, Sorin, Thermo Fisher and Qiagen. These industry players have adopted certain strategic initiatives to gain competitive advantage and achieve sustainable profits. For instance, in January 2017, Grifols acquired Hologic unit working in R&D facility manufacturing assays and instruments based on nucleic acid testing technology. This acquisition will help in expanding the company’s product portfolio.

Browse key industry insights from this 2018 report Europe In-vitro Diagnostics Market @ https://www.graphicalresearch.co...

Segments We Cover:

Europe In-vitro Diagnostics Market, By Product Type (USD million)

Reagents & kits

Instruments

Europe In-vitro Diagnostics Market, By Service Type (USD million)

Data Management Software

Services

Europe In-vitro Diagnostics Market, By Technology (USD million)

Clinical Chemistry

Immunoassay/Immunochemistry

Molecular Diagnostics

Hematology

Microbiology

Coagulation and Hemostasis

Urinalysis

Other

Europe In-vitro Diagnostics Market, By Application (USD million)

Oncology

Infectious Diseases

Diabetes

Cardiology

Nephrology

Autoimmune Diseases

Drug Testing/Pharmacogenomics

Other

Europe In-vitro Diagnostics Market, By End-user (USD million)

Hospitals

Point-Of-Care Testing

Laboratories

Academic Institutes

Other

The above information is provided for the following regions and countries:

France

Italy

Spain

Related Reports:

1. Asia Pacific In-vitro Diagnostics Market Size By Product Type , By Service Type (Data Management Software, Services), By Technology , By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics) By End-User, Industry Analysis Report, Country Outlook (China, Japan, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), Application Potential, Competitive Market Share & Forecast, 2018 – 2024

https://www.graphicalresearch.co...

2. North America In-vitro Diagnostics Market Size By Product Type (Reagents & Kits, Instruments), By Service Type (Data Management Software, Services), By Technology, By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics) By End-User (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2018 – 2024

https://www.graphicalresearch.co...

About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Parikhit B. Corporate sales, Graphical Research Email: [email protected] Web: https://www.graphicalresearch.com/ Connect with us: Facebook | Google+ | LinkedIn | Twitter

#Europe In-vitro Diagnostics Market #In-vitro Diagnostics Market #In-vitro Diagnostics

0 notes

itsnak001-blog · 6 years ago

Text

In Vitro Diagnostics (IVDs) Market 2018 Competitive Landscape Analysis

In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to: Help detect infection, Diagnose a medical condition, Prevent disease and Monitor drug therapies. Devices can range from simple tests to sophisticated DNA technology including reagents, calibrators, control materials, kits, software, and related instruments. IVD is an important segment in the global healthcare industry. The marketplace is witnessing rapid growth fuelled by technological advancements, better diagnostic tools, improved treatment monitoring, and increased availability of over-the-counter tests. IVDs add significant value to treatment processes and medical diagnoses, enhancing the well-being of the general public.

Get Free Sample Copy of Report at https://www.researchformarkets.com/sample/global-in-vitro-diagnostics-ivds-market-128064

The major manufacturers covered in this report Bio-Rad Laboratories, Thermo Fisher Scientific, Johnson and Johnson, Becton, Dickinson and Company, Abbott Laboratories, Sysmex Corporation, Diasorin S.P.A. , Roche Diagnostics, Siemens Healthcare and Danaher Corporation.

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America

Europe

China

Japan

India

Southeast Asia

Other regions (Central & South America, Middle East & Africa)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Immunology

Hematology

Clinical Chemistry

Molecular Diagnostics

Coagulation

Microbiology

Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Hospital

Laboratory

Home Care

Others

Browse Complete Report at https://www.researchformarkets.com/reports/global-in-vitro-diagnostics-ivds-market-128064

The study objectives of this report are:

To analyze and study the global In Vitro Diagnostics (IVDs) sales, value, status (2013-2017) and forecast (2018-2025).

Focuses on the key In Vitro Diagnostics (IVDs) manufacturers, to study the sales, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Place Direct Purchase Order of In Vitro Diagnostics (IVDs) Market at https://www.researchformarkets.com/buy-now/global-in-vitro-diagnostics-ivds-market-128064/one

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Contact Info:

Name: Research For Markets

Email: [email protected]

Phone: +44 8000-4182-37

#In Vitro Diagnostics (IVDs) In Vitro Diagnostics (IVDs) Market Global In Vitro Diagnostics (IVDs) Market

0 notes

precisemarketreportsandinsights · 6 years ago

Text

Point of Care Testing Market Expected to be Valued at USD 30 Billion by 2022: Radiant Insights, Inc

11 October 2018: Point-of-Care testing can be defined as the medical diagnostic testing performed outside the clinical laboratory near to the place where the patient is receiving treatment. This type of testing is performed by non-laboratory personnel and the results are used for clinical decision making. The Point-of-Care tests have immense potential to improve global health, and to eventually reduce public and national spending on health.

The Point-of-Care testing devices have now found applications in a large number of medical conditions. Due to its increased usage in the field of critical care settings to deliver decentralized, patient-centric healthcare to the patients, the projections for the global Point-of-Care testing market is expected to witness a rapid growth. It is predicted that by 2022, the global Point-of-Care testing market will reach U$$ 30 Billion.

Request A Sample Copy of This Report at: https://www.radiantinsights.com/research/global-point-of-care-testing-market/request-sample

As per RNCOS report “Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022”, the global Point-of-Care testing market is anticipated to witness a rapid growth during 2016-2022. This report provides a detailed analysis of the current and future market scenario of the global Point-of-Care testing market with a brief outlook of the IVD industry. The report provides insight about the major drivers, such as increasing awareness about POCT, technological advancements, increasing FDA approvals, for the global Point-of-Care testing market.

Furthermore, few challenges, such as product recalls and lack of regulatory standards, hindering the growth of the global Point-of-Care testing market have also been mentioned in the report. In addition, the report also highlights various opportunities available for growth of the global Point-of-Care testing market. Various trends and developments in the industry have also been cited in the report.

Browse Full Research Report with TOC on https://www.radiantinsights.com/research/global-point-of-care-testing-market

The global Point-of-Care testing market has been segmented on the basis of type of product. The major types of Point-of-Care testing present in the market include glucose monitoring kits, blood gas and electrolyte analysers, pregnancy & fertility testing kits, cardiac markers, infectious diseases testing kits, coagulation monitoring kits and drug-of-abuse testing kits amongst others. According to the report, glucose monitoring kits accounted for the largest share in 2016 due rising prevalence of diabetes & technological advancements in self-monitoring of blood glucose. Based on geography, the report divides the market into North America, Europe, Asia-Pacific, and Rest of the World. In 2016, North America accounted for the largest share.

The last section of the report discusses about the prominent players in global Point-of-Care testing market. A brief business overview and financial information about each of these players has been provided, along with their product portfolios. The recent developments of every player have also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Point-of-Care testing market.

About Radiant Insights Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact: Michelle Thoras 201 Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States Tel: 1-415-349-0054 Toll Free: 1-888-928-9744 Mail: [email protected]

#Point of Care Testing Market #Point of Care Testing Industry #Point of Care Testing Market Share #Point of Care Testing Market Scope #Point of Care Testing Market Demand

0 notes